Does Medication related Osteonecrosis of the Jaw Affect Maxillary Sinus Volume and Mucosal Thickness?

Creative Commons License

YILMAZ ASAN C., GÖNEN Z. B., Akkoyun E. F., KILIÇ E., ALKAN A.

MEANDROS MEDICAL AND DENTAL JOURNAL, vol.21, no.1, pp.12-18, 2020 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 21 Issue: 1
  • Publication Date: 2020
  • Doi Number: 10.4274/meandros.galenos.2018.44366
  • Journal Name: MEANDROS MEDICAL AND DENTAL JOURNAL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.12-18
  • Keywords: Maxillary sinus, bisphosphonate osteonecrosis, BISPHOSPHONATE-RELATED OSTEONECROSIS, SURGEONS POSITION PAPER, ZOLEDRONIC-ACID, IN-VITRO, AMERICAN ASSOCIATION, RISK-FACTORS, CANCER, PAMIDRONATE, MANAGEMENT
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

Objective: Bisphosphonates (BPs) are commonly prescribed drugs because of their antiresorptive effects. However, BPs may cause medication-related osteonecrosis of the jaw (MRONJ). This study aimed to compare the maxillary sinus volumes and mucosal thickening of patients with MRONJ and healthy patients.